Tai Sandi See insider trades
Open-market stock purchases and sales by Tai Sandi See, Chief Development Officer at Lexeo Therapeutics, Inc, from SEC Form 4 filings since Jan 7, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Nov 18, 2025 | LXEO Lexeo Therapeutics, Inc | Sold | $3.6K |
Companies traded
- LXEO Lexeo Therapeutics, Inc: 6 sales, last Nov 18, 2025